On ECHEMI
Home > Drugs > Tianjin Huairen Pharmacy Co., Ltd.
Tianjin Huairen Pharmacy Co., Ltd.
  • Founded in:

    1996-04-09
  • Country:

    China China
  • Address:

    No. 25, Hongyuan Road, Xiqing Economic Development Zone, Tianjin
  • Tax NO.:

    911201112389964770
  • Registered Funds:

    30 million yuan
  • Website:

  • Email:

Related Drugs
Breviscapine chewable tablets
Breviscapine.
Name Description Content CAS NO. Registered Holders
BREVISCAPIN

Extract from the above information

More

Extract from the above information

116122-36-2 0
Iron Dextran Tablets
The main ingredient of this product is iron dextran.
Name Description Content CAS NO. Registered Holders
Iron-dextran

This product is a complex of dextran and iron, which is soluble iron. Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron deficiency anemia. Oral administration of this product can supplement iron and correct iron deficiency anemia.

More

This product is a complex of dextran and iron, which is soluble iron. Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron deficiency anemia. Oral administration of this product can supplement iron and correct iron deficiency anemia.

9004-66-4 14
Telmisartan Tablets
The main ingredient of this product is telmisartan.
Name Description Content CAS NO. Registered Holders
Telmisartan

Telmisartan is a specific angiotensin II receptor (ATⅠ type) antagonist that binds to the ATⅠ receptor subtype with high affinity, has no agonist effect, and selectively binds for a long time. It does not inhibit human plasma renin, ion channels or angiotensin converting enzyme II, and does not affect the action of bradykinin. 80 mg can almost completely inhibit the increase in blood pressure caused by angiotensin II, and the antihypertensive effect lasts for more than 24 hours. It takes effect within 3 hours after the first dose and reaches the maximum antihypertensive effect in 4 weeks. There is no rebound hypertension after sudden discontinuation of the drug. The incidence of dry cough in clinical trials is lower than that in the angiotensin converting enzyme inhibitor treatment group.

More

Telmisartan is a specific angiotensin II receptor (ATⅠ type) antagonist that binds to the ATⅠ receptor subtype with high affinity, has no agonist effect, and selectively binds for a long time. It does not inhibit human plasma renin, ion channels or angiotensin converting enzyme II, and does not affect the action of bradykinin. 80 mg can almost completely inhibit the increase in blood pressure caused by angiotensin II, and the antihypertensive effect lasts for more than 24 hours. It takes effect within 3 hours after the first dose and reaches the maximum antihypertensive effect in 4 weeks. There is no rebound hypertension after sudden discontinuation of the drug. The incidence of dry cough in clinical trials is lower than that in the angiotensin converting enzyme inhibitor treatment group.

144701-48-4 109
Simvastatin Tablets
The main ingredients and their chemical names are: Simvastatin, [1S-[1a, 3a, 7b (2S*, 4S*) 8ab]]-1,2., 3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthyl-2,2-dimethylbutyrate. Molecular formula: C25H38O5, molecular weight: 418.57
Name Description Content CAS NO. Registered Holders
Simvastatin

This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C).

More

This product is a methylhydroxyglutaryl coenzyme A (HMG-COA) reductase inhibitor, which inhibits the synthesis of endogenous cholesterol and is a blood lipid regulator. Literature data show that it can reduce the cholesterol (TC) content in the serum, liver, and aorta of hyperlipidemia rabbits, and reduce the levels of very low density lipoprotein cholesterol (VLDL-C) and low density lipoprotein cholesterol (LDL-C).

79902-63-9 63
Fluconazole Capsules
The main ingredient of this product is fluconazole
Name Description Content CAS NO. Registered Holders
Fluconazole

Fluconazole is a new triazole antifungal drug with a broad-spectrum antifungal effect. It can selectively inhibit the sterol synthesis of fungi. It is effective against Candida infection, Cryptococcus neoformans infection, Malassezia sacchariflora, Microsporum, Trichophyton, Epidermophyton, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, Peyer's Chromatid, and Cladosporium carinii. It has a highly selective inhibitory effect on fungal cytochrome p-450-dependent enzymes.

More

Fluconazole is a new triazole antifungal drug with a broad-spectrum antifungal effect. It can selectively inhibit the sterol synthesis of fungi. It is effective against Candida infection, Cryptococcus neoformans infection, Malassezia sacchariflora, Microsporum, Trichophyton, Epidermophyton, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, Peyer's Chromatid, and Cladosporium carinii. It has a highly selective inhibitory effect on fungal cytochrome p-450-dependent enzymes.

86386-73-4 69
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.